Surgical Equipment Market is estimated to be valued at USD 12.26 Bn in 2025 and is expected to reach USD 17.48 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to 2032.
The Surgical Equipment Market is witnessing steady expansion, propelled by the increasing volume of surgical procedures worldwide and rising demand for minimally invasive techniques. Handheld instruments lead the market with an 83.8% share, reflecting their versatility and essential role across specialties. Growing investments in surgical infrastructure, surgeon preference for precision tools, and patient demand for faster recovery are shaping market dynamics and fostering continuous innovation in surgical instrumentation.
|
Current Event |
Description and its impact |
|
Technological Advancements and Equipment Upgrades |
|
|
Strategic Collaborations and Market Penetration |
|
|
Regulatory Changes and Economic Stimuli |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The reimbursement landscape for surgical equipment is evolving, particularly with the growing shift toward outpatient and ambulatory surgical settings. In the U.S., the Centres for Medicare & Medicaid Services (CMS) has introduced favorable changes, including a 2.9% increase in ASC reimbursement rates for 2025 and a reduction in the device-intensive procedure threshold from 40% to 30%. These adjustments enhance the financial feasibility of using advanced and costly surgical tools in outpatient procedures.
However, most surgical instruments are reimbursed under bundled payments, limiting separate claims for individual devices unless they meet specific criteria. This challenges providers when adopting high-end technologies like robotic-assisted systems. Globally, reimbursement varies by region public healthcare systems in Europe often emphasize cost-effectiveness, while private insurers in regions like Asia-Pacific may offer more flexibility.
As surgical practices evolve, aligning reimbursement structures with technological advancements will be crucial to ensure sustained innovation and accessibility in the surgical equipment market.
Increase in the preference for robotic surgery, owing to its better precision, flexibility, and control, as compared to the conventional methods is expected to drive the market growth over the forecast period. For instance, Medtronic plc. A healthcare technology company, announced three significant global market-entrance and indication expansion approvals for its Hugo robotic-assisted surgery (RAS) system.
The product has enhanced visualization and instrumentation, secure and seamless video recording options, modular and portable, accessible and scalable. These approvals include CE mark clearance for general surgery indication, Health Canada license for general laparoscopic surgery indication, and Ministry of Health, Labour and Welfare (MHLW) approval for urological and gynaecological indications in Japan.
The approvals received by the company will further help the company to expand into key robotic markets. Hence, this is expected to fuel the surgical equipment market growth over the forecast period.
Rising geriatric population is also expected to drive the surgical equipment market growth during the forecast period. It is expected that individuals that are aged 60 and above are more prone towards developing disorders that requires surgery, as compared to the younger population. For instance, according to Centres for Disease Control and Prevention, around 320,900 reported hip replacements were performed among people aged 45 and above in 2020.
Moreover, various advancements in the technology of hip replacement’s surgical equipment is also expected to fuel the overall market growth. For instance, on January 26, 2022, Smith + Nephew, a medical technology company, announced the expansion of indications on its CORI Surgical System. It is the most advanced and efficient handheld robotic- solution in total knee arthroplasty surgery.
The company’s RI.HIP NAVIGATION is designed to help in maximizing accuracy and reproducibility by delivering patient-specific component alignment for total hip arthroplasty (THA). The incorporation of RI.HIP NAVIGATION in CORI Surgical Systems will further help the company in strengthening real intelligence digital ecosystem.
In June 2025, the Times reported that robotic‑assisted surgery is revolutionizing UK healthcare, with the NHS projecting that 90 % of keyhole surgeries will be robot‑led within a decade up from the current 20 %. Surgical robots currently cost between £500,000 and £1.5 million, and companies like Intuitive Surgical and investors like Worldwide Healthcare Trust are actively involved, though recent investment returns have been weak.
Handheld surgical equipment is expected to lead the global surgical equipment market in 2025, capturing approximately 83.8% of the total market share. This stronghold is attributed to their critical role across a wide range of surgical disciplines, including general surgery, orthopaedics, cardiovascular, and obstetrics.
Instruments such as forceps, scalpels, scissors, and retractors remain indispensable due to their durability, ease of sterilization, reusability, and surgeon preference for tactile precision. The widespread surgical equipment usage in hospitals is a key driver of this dominance, as these tools form the backbone of nearly all routine and complex surgical procedures performed in both inpatient and outpatient settings.
The surge in surgical procedures globally driven by rising incidences of chronic illnesses, trauma cases, and an aging population continues to bolster demand for high-performance manual instruments. Moreover, ongoing advancements in ergonomic design, material innovation, and safety enhancements are further elevating their utility.
As healthcare providers focus on improving surgical outcomes and operational efficiency, handheld instruments are poised to remain at the forefront of surgical practice, sustaining their dominance well beyond 2025.
To learn more about this report, Download Free Sample
Europe is projected to dominate the global surgical equipment market, commanding approximately 37.00% of total revenue share by 2025. This regional leadership is underpinned by the presence of a highly developed healthcare ecosystem, significant surgical procedure volumes, and early adoption of advanced surgical technologies.
Europe healthcare providers are also rapidly integrating robotic-assisted, AI-driven, and minimally invasive surgical tools into their operative protocols, enhancing precision and improving patient outcomes. These innovations in surgical equipment are transforming the surgical landscape enabling greater accuracy, reducing patient recovery time, and lowering complication risks. With patient demand for outpatient care rising and innovation continuing to reshape surgical practices, Europe is well-positioned to maintain its leadership in the global surgical equipment market through and beyond 2025.
The United States is the leading force in the global surgical equipment market, significantly contributing to North America’s projected 34.0% market share by 2025. A vast network of ambulatory surgery centres (ASCs), a high volume of surgical procedures, and consistent technological innovation fuel this dominance.
The U.S. benefits from advanced reimbursement systems, strong regulatory frameworks, and aggressive investment in minimally invasive and robotic-assisted surgical technologies. With major players like Medtronic, Stryker, and Johnson & Johnson headquartered in the country, the U.S. continues to drive product innovation, market penetration, and global influence in the surgical equipment space.
Canada plays a vital supporting role in the North American surgical equipment market, benefiting from its universal healthcare system and rising investment in surgical infrastructure. Canadian hospitals are increasingly integrating advanced surgical equipment and minimally invasive technologies to reduce patient recovery time and hospital stays.
Government initiatives to modernize operating rooms and improve surgical wait times are boosting demand for high-precision surgical instruments. With a growing emphasis on outpatient surgeries and sustainable procurement practices, Canada is steadily strengthening its presence in the global surgical equipment landscape.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.26 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.2% | 2032 Value Projection: | USD 17.48 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Medtronic plc., Peters Surgical SASU, Ethicon (Johnsons & Johnsons), Conmed Corporation, Novartis International AG, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Cousin-Biotech, Enthral Medical GMBH, Fuhrmann GMBH, Integral Lifesciences Holdings Corporation, KLS martin Group, Stryker Corporation, Zimmer Biomet, Dextera Surgical, Hospira, and SIM Surgical |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
